← back to search

Paul van Diest

Utrecht University · NL
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research focused on SOX4 and Angiogenesis, with related work in Grading (engineering), Drug response, Twist transcription factor. Notable publications include 'The 2019 World Health Organization classification of tumours of the breast', 'Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses', and 'Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis'.
h-index
citations
1,435
works
5
NIH funding
primary concept
email

Recent publications

Twist activates miR-22 to suppress estrogen receptor alpha in breast cancer
Molecular and Cellular Biochemistry 2021cited by 23position: middledoi
The 2019 World Health Organization classification of tumours of the breast
Histopathology 2020cited by 1,056position: middledoi
Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses
Cell Reports 2020cited by 303position: middledoi
Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis
eLife 2018cited by 53position: middledoi
Author response: Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis
2018cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eric W.‐F. Lam · Rutgers, The State University of New Jersey2 papers (2018–2018)Miranda van Amersfoort · Utrecht University2 papers (2018–2018)Michal Mokrý · Utrecht University2 papers (2018–2018)Olivier G. de Jong · Utrecht University2 papers (2018–2018)Carlos Caldas · Concern Foundation2 papers (2018–2018)Elsken van der Wall · Utrecht University2 papers (2018–2018)Ana Rita Lourenço · University of Birmingham2 papers (2018–2018)Jeroen F. Vermeulen · Utrecht University2 papers (2018–2018)José Luís Sandoval · University of Geneva2 papers (2018–2018)M. Guy Roukens · Genmab (United States)2 papers (2018–2018) · 2 papers (2018–2018)Ana Tufegdžić Vidaković · Cancer Research UK Cambridge Center2 papers (2018–2018)Cynthia Lisanne Frederiks · Utrecht University2 papers (2018–2018)Laura Bella · University of Ferrara2 papers (2018–2018)Patrick W.B. Derksen · Utrecht University2 papers (2018–2018)Cathy B. Moelans · Utrecht University2 papers (2018–2018)Marianne C. Verhaar · University of Applied Sciences Utrecht2 papers (2018–2018)Edward E. S. Nieuwenhuis · Princess Máxima Center2 papers (2018–2018)Paul J. Coffer · Utrecht University2 papers (2018–2018)Stephin J. Vervoort · Utrecht University2 papers (2018–2018)